TickerFactsScreenerDevelopers

Iterum Therapeutics plc (ITRMF) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$11.30M2017: -$30.60M2018: -$77.25M2019: -$81.92M2020: -$54.53M2021: -$15.84M2022: -$18.47M2023: -$39.33M2024: -$26.77M-$26.77M
2016Operating Cash Flow (USD)2024
Fiscal YearOperating Cash FlowChange YoY
2024-$26.77M+31.9%
2023-$39.33M-112.9%
2022-$18.47M-16.6%
2021-$15.84M+70.9%
2020-$54.53M+33.4%
2019-$81.92M-6.0%
2018-$77.25M-152.4%
2017-$30.60M-170.9%
2016-$11.30M—